SCHEMBL8285182

SCHEMBL8285182

COCCOc1nc2c(cc1F)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.39
GSK3B P49841 3/20 0.36
BTK Q06187 3/20 0.36
EGFR P00533 2/20 0.36
ITK Q08881 2/20 0.36
CDK4 P11802 2/20 0.36
CCND1 P24385 2/20 0.36
CCND2 P30279 2/20 0.36
CCND3 P30281 2/20 0.36
CYP1A2 P05177 3/20 0.36
CLK4 Q9HAZ1 2/20 0.36
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
SYK P43405 1/20 0.35
CYP3A4 P08684 2/20 0.35
TSHR P16473 1/20 0.35
ALDH1A2 O94788 1/20 0.35
ALDH1A1 P00352 1/20 0.35
ALDH1A3 P47895 1/20 0.35
MAT2A P31153 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287374 0.89 PDE11A (0.40) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL5872005 0.88 MAT2A (0.43) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8285178 0.83 KCNH3 (0.41) PDE11ACYP1A2CLK4LMNAMAPK1
SCHEMBL8285172 0.83 PDE11A (0.40) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL5872009 0.80 PDE11A (0.44) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL5871661 0.79 PDE11A (0.42) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL5871610 0.78 MEN1 (0.43) PDE11ABTKEGFRITKCYP1A2
SCHEMBL5872062 0.78 PDE11A (0.44) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8287521 0.77 PDE11A (0.40) PDE11AGSK3BEGFRCDK4CCND1
SCHEMBL8287383 0.76 PDE11A (0.41) PDE11AGSK3BBTKEGFRCDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed